279 related articles for article (PubMed ID: 15642983)
21. Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease: systematic review and meta-analysis.
Shibata Y; Horita N; Yamamoto M; Tsukahara T; Nagakura H; Tashiro K; Watanabe H; Nagai K; Nakashima K; Ushio R; Ikeda M; Narita A; Kanai A; Sato T; Kaneko T
Sci Rep; 2016 Jul; 6():29325. PubMed ID: 27373718
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of plasma anti-GPL-core IgA and IgG for diagnosis of disseminated non-tuberculous mycobacteria infection.
Nithichanon A; Samer W; Chetchotisakd P; Kewcharoenwong C; Ato M; Lertmemongkolchai G
PLoS One; 2020; 15(11):e0242598. PubMed ID: 33253290
[TBL] [Abstract][Full Text] [Related]
23. Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA.
Kitada S; Levin A; Hiserote M; Harbeck RJ; Czaja CA; Huitt G; Kasperbauer SH; Daley CL
Eur Respir J; 2013 Aug; 42(2):454-60. PubMed ID: 23100506
[TBL] [Abstract][Full Text] [Related]
24. [Structure and antigenicity of the glycopeptidolipid antigen of Mycobacterium avium-intracellulare complex (MAC) serovar 16].
Nishikawa K
Kekkaku; 1998 Apr; 73(4):295-306. PubMed ID: 9613050
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of patients with bronchoscopy-diagnosed pulmonary Mycobacterium avium complex infection.
Urabe N; Sakamoto S; Sano G; Ito A; Homma S
J Infect Chemother; 2018 Oct; 24(10):822-827. PubMed ID: 30054229
[TBL] [Abstract][Full Text] [Related]
26. Serodiagnostic potential of Mycobacterium avium MAV2054 and MAV5183 proteins.
Shin AR; Lee KS; Lee KI; Shim TS; Koh WJ; Jeon HS; Son YJ; Shin SJ; Kim HJ
Clin Vaccine Immunol; 2013 Feb; 20(2):295-301. PubMed ID: 23269416
[TBL] [Abstract][Full Text] [Related]
27. Application of a commercial serodiagnostic kit that measures the serum anti-glycopeptidolipid core IgA antibody in Mycobacterium avium complex pulmonary disease.
Kitada S
Respir Investig; 2019 Sep; 57(5):410-414. PubMed ID: 31085120
[TBL] [Abstract][Full Text] [Related]
28. Serum GPL core antibody levels are associated with disease activity and treatment outcomes in Mycobacterium avium complex lung disease following first line antibiotic treatment.
Fukushima K; Kitada S; Matsumoto Y; Komukai S; Kuge T; Kawasaki T; Matsuki T; Motooka D; Tsujino K; Miki M; Miki K; Nakamura S; Kida H
Respir Med; 2021 Oct; 187():106585. PubMed ID: 34455309
[TBL] [Abstract][Full Text] [Related]
29. Serological test and chest computed tomography findings in patients with Mycobacterium avium complex lung disease.
Kitada S; Nishiuchi Y; Hiraga T; Naka N; Hashimoto H; Yoshimura K; Miki K; Miki M; Motone M; Fujikawa T; Kobayashi K; Yano I; Maekura R
Eur Respir J; 2007 Jun; 29(6):1217-23. PubMed ID: 17251234
[TBL] [Abstract][Full Text] [Related]
30. Mycobacterium avium Complex Pleuritis with Elevated Anti-glycopeptidolipid-core IgA Antibody Levels in Pleural Effusion.
Furuuchi K; Morimoto K; Fujiwara K; Tanaka Y; Takemura T; Kurashima A; Yoshimori K; Ohta K; Sasaki Y
Intern Med; 2019 Sep; 58(17):2577-2579. PubMed ID: 31118400
[TBL] [Abstract][Full Text] [Related]
31. [Usefulness of MycoDot test for the detection of anti-mycobacterial antibodies as an aid in the diagnosis of experimental Mycobacterium tuberculosis and Mycobacterium avium complex infections in mice].
Sato K; Shimizu T; Akaki T; Tomioka H
Kekkaku; 1998 Feb; 73(2):47-52. PubMed ID: 9545696
[TBL] [Abstract][Full Text] [Related]
32. Association between serum anti-glycopeptidolipid-core IgA antibody titers and clinical characteristics of Mycobacterium avium complex pulmonary disease.
Kodaka N; Nakano C; Oshio T; Watanabe K; Niitsuma K; Imaizumi C; Shimada N; Morita H; Matsuse H
Int J Infect Dis; 2021 Aug; 109():155-159. PubMed ID: 34174432
[TBL] [Abstract][Full Text] [Related]
33. Serum immunoglobulin a antibodies to glycopeptidolipid core antigen for
Kobayashi T; Tsuyuguchi K; Yoshida S; Kurahara Y; Minomo S; Inoue Y; Suzuki K
Int J Mycobacteriol; 2020; 9(1):76-82. PubMed ID: 32474493
[TBL] [Abstract][Full Text] [Related]
34. [CHANGES IN MAC ANTIBODY LEVELS BEFORE AND AFTER SURGERY AND AT THE TIME OF RELAPSE/RECURRENCE IN MAC LUNG DISEASE--Can MAC Antibodies Be an Indicator of Postoperative Relapse/Recurrence?].
Yamada K; Kawasumi Y; Yasuda A; Seki Y; Adachi T; Tarumi O; Hayashi Y; Nakagawa T; Yamada N; Ogawa K
Kekkaku; 2016 Feb; 91(2):41-4. PubMed ID: 27263223
[TBL] [Abstract][Full Text] [Related]
35. Serodiagnosis of Mycobacterium avium complex disease in humans: translational research from basic mycobacteriology to clinical medicine.
Kobayashi K
Jpn J Infect Dis; 2014; 67(5):329-32. PubMed ID: 25241680
[TBL] [Abstract][Full Text] [Related]
36. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
37. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel tetrapeptide structure of the Mycobacterium avium glycopeptidolipid that functions as a specific target for the host antibody response.
Matsunaga I; Komori T; Mori N; Sugita M
Biochem Biophys Res Commun; 2012 Mar; 419(4):687-91. PubMed ID: 22382026
[TBL] [Abstract][Full Text] [Related]
39. Serological diagnosis of
Tam WO; Wong CF; Wong SSY; Kwan CLY
J Clin Tuberc Other Mycobact Dis; 2020 Dec; 21():100189. PubMed ID: 32995571
[TBL] [Abstract][Full Text] [Related]
40. Determination of humoral immunoglobulins M and G directed against mycobacterial antigen 60 failed to diagnose primary tuberculosis and mycobacterial adenitis in children.
Turneer M; Van Nerom E; Nyabenda J; Waelbroeck A; Duvivier A; Toppet M
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1508-12. PubMed ID: 7952608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
